Clinical Trial Update: A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial to evaluate the safety and tolerability of BBM-P002 in Parkinson's disease. The study, sponsored by Shanghai Xinzhi BioMed Co.,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BBM-P002

Snippet

Sponsor: Shanghai Xinzhi BioMed Co., Ltd. | Conditions: PD | Phase 1 | Status: RECRUITING